Keam, B. and Machiels, J.-P. and Kim, H.R. and Licitra, L. and Golusinski, W. and Gregoire, V. and Lee, Y.G. and Belka, C. and Guo, Y. and Rajappa, S.J. and Tahara, M. and Azrif, M. and Ang, M.K. and Yang, M.-H. and Wang, C.-H. and Ng, Q.S. and Wan Zamaniah, W.I. and Kiyota, N. and Babu, S. and Yang, K. and Curigliano, G. and Peters, S. and Kim, T.W. and Yoshino, T. and Pentheroudakis, G. (2021) Pan-Asian adaptation of the EHNS–ESMO–ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck. ESMO Open, 6 (6). ISSN 20597029, DOI https://doi.org/10.1016/j.esmoop.2021.100309.
Full text not available from this repository.Abstract
The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of squamous cell carcinoma (SCC) of the oral cavity, larynx, oropharynx and hypopharynx was published in 2020. It was therefore decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special, virtual guidelines meeting in July 2021 to adapt the ESMO 2020 guidelines to consider the potential ethnic differences associated with the treatment of SCCs of the head and neck (SCCHN) in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with SCCHN (excluding nasopharyngeal carcinomas) representing the oncological societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of the current treatment practices and drug access restrictions in the different Asian countries. The latter was discussed when appropriate. This manuscript provides a series of expert recommendations (Clinical Practice Guidelines) which can be used to provide guidance to health care providers and clinicians for the optimisation of the diagnosis, treatment and management of patients with SCC of the oral cavity, larynx, oropharynx and hypopharynx across Asia. © 2021 The Authors
| Item Type: | Article |
|---|---|
| Funders: | ASCO AP Regional Council, Amgen Malaysia, Celgene International, Greater Petaling Cancer City Challenge UICC, Pfizer Malaysia, et. all |
| Uncontrolled Keywords: | Carcinoma, Squamous Cell; Follow-Up Studies; Head and Neck Neoplasms; Humans; Medical Oncology; Squamous Cell Carcinoma of Head and Neck |
| Subjects: | R Medicine > RC Internal medicine R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
| Divisions: | Faculty of Medicine > Clinical Oncology Department |
| Depositing User: | Ms Zaharah Ramly |
| Date Deposited: | 17 Oct 2024 08:40 |
| Last Modified: | 17 Oct 2024 08:40 |
| URI: | http://eprints.um.edu.my/id/eprint/35826 |
Actions (login required)
 |
View Item |
